Long noncoding LUCAT1 promotes cisplatin resistance of non-small cell lung cancer by promoting IGF-2.

Wang W, Dong ML, Zhang W, Liu T

Open source

DOI
10.26355/eurrev_201906_18188
Published
2019 Jun
Container
European review for medical and pharmacological sciences
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201906_18188,
  title = {Long noncoding LUCAT1 promotes cisplatin resistance of non-small cell lung cancer by promoting IGF-2.},
  author = {Wang W and Dong ML and Zhang W and Liu T},
  year = {2019},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_201906_18188},
  url = {https://doi.org/10.26355/eurrev_201906_18188}
}

RIS

TY  - JOUR
TI  - Long noncoding LUCAT1 promotes cisplatin resistance of non-small cell lung cancer by promoting IGF-2.
AU  - Wang W
AU  - Dong ML
AU  - Zhang W
AU  - Liu T
PY  - 2019
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_201906_18188
UR  - https://doi.org/10.26355/eurrev_201906_18188
ER  - 

APA

W, W., ML, D., W, Z., & T, L. (2019). Long noncoding LUCAT1 promotes cisplatin resistance of non-small cell lung cancer by promoting IGF-2.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201906_18188

Source records